Results 131 to 140 of about 342,467 (304)

Skin-Limited Graft-versus-Host Disease after Pancreatic Transplantation

, 2017
Introduction. The phenomenon of graft-versus-host disease, a solid organ transplant recipient, is a rare development with a very poor prognosis. Case Presentation.
Amit Sharma, Elika Hoss, Hasan Khamash, David J. DiCaudo, Muneeb Ilyas, Mark R. Pittelkow   +5 more
core   +1 more source

Injectable Bone Cements: A Generational Framework for Bioactivity, Porosity, and Mechanobiological Design at the Nanoscale

Advanced NanoBiomed Research, EarlyView.
Key demographic, biological, and material considerations that drive the need for advanced injectable bone cement technologies. Injectable bone cements (IBCs) are widely used in orthopaedic and craniofacial applications due to their minimally invasive delivery and ability to provide early mechanical stabilisation.
Frank Fei, Yogambha Ramaswamy, Young Jung No   +2 more
wiley   +1 more source

Second allogeneic transplants in children: twelve years of experience

Biomédica: revista del Instituto Nacional de Salud
Introduction. A second hematopoietic stem cell transplant is required when the first transplant fails, usually due to relapse or graft failure, and is associated with increased morbidity and mortality.
Alexis Antonio Franco, Eliana Manzi Tarapues, Sergio Camilo Cabrera Salcedo, Diana Marcela Muñoz Caluce, Diego Medina   +4 more
doaj   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 CAR‐T Cell Therapy in Progressive Systemic Sclerosis

Arthritis &Rheumatology, Accepted Article.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T‐cell therapy in patients with progressive systemic sclerosis. Methods Patients with progressive systemic sclerosis received CD19 CAR‐T cell therapy and were followed longitudinally for safety, clinical efficacy, immune ...
Chenhan Jia, Wanyi Lin, Zhangyi Zhao, Fenglin Wu, Chaoyu Gu, Yuankai Sun, Zhe Ding, Chang Wei, Xinyu Li, Cuiwei Xie, Peng Xia, Zhen Xia, Xuesong Liu, Shaoying Yang, Chunyan Zhang, Hanlin Yin, Liangjing Lu   +16 more
wiley   +1 more source

Adult human mesenchymal stromal cells and the treatment of graft versus host disease

, 2014
Richard P Herrmann, Marian J Sturm Cell and Tissue Therapies, Western Australia, Royal Perth Hospital, Wellington Street, Perth, WA, Australia Abstract: Graft versus host disease is a difficult and potentially lethal complication of hematopoietic stem ...
Herrmann RP, Sturm MJ
core  

Immunologic tolerance to skin allograft after graft-versus-host disease.

, 2007
We report the observation of a young girl suffering from acute myeloid luekemia who developed chronic graft-versus-host disease with major skin involvement after a bone marrow graft from her histocompatible brother. She developed an immunologic tolerance
VanWijck, Romain R, Weynand, Birgit, Elias, Badwi, Elias, Badwi Georges, Vanwijck, Romain, Meunier, Daniel I, Squifflet, Jean Paul, Meunier, Daniel, Marot, Liliane, Bayet, Bénédicte   +9 more
core   +1 more source

Biologic Augmentation With Biocomposite Scaffold in Revision Quadriceps Tendon Repair

Arthroscopy Techniques, EarlyView.
Abstract Quadriceps tendon rupture is a relatively uncommon injury, typically occurring in middle‐aged males, and is often associated with systemic comorbidities or trauma. Although primary repair techniques provide excellent outcomes when performed acutely, revision surgery presents unique challenges due to poor tissue quality and compromised ...
Cory N. Meixner, Emma L. Flanigan, David C. Flanigan   +2 more
wiley   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir–ritonavir in patients with COVID‐19

British Journal of Clinical Pharmacology, EarlyView.
Aims The repurposed use of favipiravir in COVID‐19 has been reported to have limited clinical efficacy, yet it has been widely used in some countries. Favipiravir causes mutagenesis in RNA viruses, and it is currently unknown whether it may have a measurable effect on the virus in humans.
Akosua A. Agyeman, Laura Buggiotti, Li‐An K. Brown, Jose A. Guerra‐Assuncao, Japhette E. Kembou‐Ringert, Wen Y. Mak, Judith Breuer, David M. Lowe, Joseph F. Standing, FLARE Investigators   +9 more
wiley   +1 more source

Severe acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids

, 2009
Acute graft vs host disease is an uncommon and usually fatal complication of lung transplant for which no effective therapy exists. All 8 patients with grade 3 to 4 acute graft vs host disease after lung transplantation described in literature died ...
LAGHI PASINI F., FILIPPI R., LUZZI L., FOSSI A., VOLTOLINI L., MARCHI B., ROTTOLI P., GOTTI G.   +7 more
core